Drug
Eis 12656
Eis 12656: highest development phase Phase 1/2, developed by Eisbach Bio GmbH. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Eisbach Bio GmbH
Trials
| Drug | Phase | Indication |
|---|---|---|
| EIS-12656 NCT06525298 | Phase 1/2 | Advanced Solid Tumor |
Latest
No recent events.
Follow Eis 12656 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.